Nature's Miracle Holding Bolsa (OTC: NMHI)

Últimas noticias sobre Nature's Miracle Holding (OTC:NMHI) Bolsa

Nature's Miracle Holding

Nature's Miracle Holding Inc is a growing agriculture technology company providing Controlled Environment Agriculture (CEA) hardware products to growers in the CEA industry setting in North America. It provides hardware to design, build, and operate various indoor growing settings, including greenhouses and indoor growing spaces. Its products include Horticultural Lighting, Irrigation Systems, Power Distribution Systems, Climate Control Systems, Disinfection Systems, and Materials and Equipment. The company derives all of its revenue from the USA.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEHR

ATCH

ATPC

AVGR

CANG

CHCI

HCWC

LIDR

NMHI

PHIO

PIII

RGNX

RIME

SANG

STAF

URGN

YOSH

Las acciones de KB Home suben 9,1% tras superar expectativas de ganancias. Descubre los mayores ganadores y perdedores del mercado hoy.

Las acciones de KB Home se disparan un 9%; 20 acciones que se mueven en el premercado de EE.UU.

NATURE'S MIRACLE HLDG INC by Nature's Miracle Holding Inc.

Nature's Miracle Holding Inc

Nature's Miracle Holding Inc Warrants (08/03/2029)

Rep.&nbsp;Marjorie Taylor Greene&nbsp;(R-Ga.) has expressed apprehensions about the environmental impact of President&nbsp;Donald Trump&#8216;s AI infrastructure plan.
What Happened: Greene, in a post on social media platform X, voiced concerns about the &#8220;massive&#8221; water usage of data centers on Thursday. She raised these concerns in response to Trump&#8217;s AI Action Plan, which was unveiled on Wednesday.
&#8220;Rushed&nbsp;AI expansion and data centers&nbsp;being built all over the&nbsp;country from state to state&nbsp;with no plan in regards&nbsp;to environmental and critical water&nbsp;supply impact has massive future&nbsp;implications and problems,&#8221; Greene said.
The AI Action Plan aims to exempt &#8220;data center-related actions&#8221; from environmental review and place data center and energy projects on fast-track under the nation&#8217;s permitting system. This could potentially lead to water quality impacts.
My deep concerns are that the EO demands rapid AI expansion with little to no guardrails and breaks.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I have many concerns about the AI Executive Order signed yesterday by President Trump. While I understand the many promised benefits of AI, I remain committed to protecting state rights, human jobs, human lives, human rights, our environment and critical water supply. My deep…
&mdash; Rep. Marjorie Taylor Greene&#x1f1fa;&#x1f1f8; (@RepMTG) <a href="https://twitter.com/RepMTG/status/1948400163875152237?ref_src=twsrc%5Etfw">July 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Greene, who has a background in construction, highlighted the potential impact on the environment and water supply, emphasizing the need for a &#8220;careful and wise approach.&#8221;
She criticized the plan for rolling back AI regulations, especially at the state level, noting it would restrict federal funding to states with strict AI laws and task the FCC with reviewing whether those laws conflict with its authority.
Greene signed off saying &#8220;Competing with China does not mean become like China by threatening state rights, replacing human jobs on mass scale creating mass poverty, and creating potentially devastating effects on our environment and critical water supply.&#8221;
SEE ALSO: <a href="https://benzinga.com/news/topics/25/07/46602872/joe-rogan-says-most-americans-are-one-catastrophe-away-from-losing-everything-says-ai-and-ubi-income-" target="_blank" rel="noreferrer noopener">Joe Rogan Says Most Americans Are One Catastrophe Away From Losing Everything, Says AI And UBI Income Will Bring Chaos And Addiction</a>
Why It Matters: The AI Action Plan&#8217;s focus on fast-tracking data center construction and promoting American AI exports has been a topic of contention. President Trump&#8217;s signed the <a href="https://www.benzinga.com/markets/tech/25/07/46593182/trump-signs-new-executive-orders-to-fast-track-ai-dominance-we-will-be-unstoppable-as-a-nation">executive orders</a>, emphasizing the need for AI dominance and gain an edge over China. However, the environmental impact of these data centers has been a growing concern. 
<a href="https://www.benzinga.com/markets/tech/25/07/46487316/elon-musks-xai-unveils-sustainable-way-to-cool-memphis-data-center-amid-criticism-from-environmental-rights-groups">Elon Musk&#8217;s xAI</a> has faced backlash from environmental groups over its Memphis data center&#8217;s gas-burning turbine permit. The company later unveiled a &#8216;sustainable&#8217; way to cool its data center, but the controversy highlights the environmental challenges associated with AI infrastructure.
Against this backdrop, <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46610808/bloom-energy-stock-jumps-on-deal-to-power-oracles-ai-data-centers">companies like Bloom Energy</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) have been lauded for their sustainable power solutions for AI data centers. Shares of Bloom Energy Corp soared on Thursday, hitting a 52-week high following the announcement of a partnership with Oracle Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NASDAQ">ORCL</a>) Under the agreement, Bloom will deploy its proprietary fuel cell technology to supply onsite power for select Oracle Cloud Infrastructure data centers across the U.S.
READ MORE: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46620387/marjorie-taylor-greene-increases-these-2-stocks-in-portfolio-including-this-ai-name-up-over-100-ytd">Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/news/politics/25/07/46620387/marjorie-taylor-greene-increases-these-2-stocks-in-portfolio-including-this-ai-name-up-over-100-ytd"> </a>

Politics

ORCL

Marjorie Taylor Greene Raises 'Deep Concerns' Over Environmental Devastation In Trump's AI Action Plan: 'Competing With China Does Not Mean...'

William Blair analyst Jeff Schmitt downgrades Ameriprise Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMP#NYSE">AMP</a>) from Outperform to Market Perform.

Downgrades

Analyst Ratings

William Blair Downgrades Ameriprise Finl to Market Perform

Keefe, Bruyette &amp; Woods analyst Damon Delmonte maintains Horizon Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBNC#NASDAQ">HBNC</a>) with a Market Perform and raises the price target from $17 to $18.

Price Target

HBNC

Keefe, Bruyette & Woods Maintains Market Perform on Horizon Bancorp, Raises Price Target to $18

Cantor Fitzgerald analyst Yi Fu Lee maintains Coursera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) with a Overweight and raises the price target from $10 to $13.

COUR

Cantor Fitzgerald Maintains Overweight on Coursera, Raises Price Target to $13

Keefe, Bruyette &amp; Woods analyst Timothy Switzer reiterates Esquire Financial Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESQ#NASDAQ">ESQ</a>) with a Market Perform and raises the price target from $102 to $110.

Reiteration

Keefe, Bruyette & Woods Reiterates Market Perform on Esquire Financial Hldgs, Raises Price Target to $110

WIIM

SBET

SharpLink Gaming shares are trading higher. The company announced it had appointed a new Co-CEO

Keefe, Bruyette &amp; Woods analyst Kelly Motta maintains CVB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVBF#NASDAQ">CVBF</a>) with a Outperform and lowers the price target from $25 to $24.

CVBF

Keefe, Bruyette & Woods Maintains Outperform on CVB Financial, Lowers Price Target to $24

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ftxtav.com%2F&amp;esheet=54295685&amp;newsitemid=20250725732646&amp;lan=en-US&amp;anchor=Textron+Aviation+Inc.&amp;index=1&amp;md5=b22276e17bcd164b82e3d223fe0623ec">Textron Aviation Inc.</a>, a <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.textron.com%2F&amp;esheet=54295685&amp;newsitemid=20250725732646&amp;lan=en-US&amp;anchor=Textron+Inc.&amp;index=2&amp;md5=8153d117119b92057316aff7c25a7a17">Textron Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXT#NYSE">TXT</a>) company, today announced an agreement with Infinity Flight Group for the purchase of 10 additional <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcessna.txtav.com%2Fen%2Fpiston%2Fcessna-skyhawk&amp;esheet=54295685&amp;newsitemid=20250725732646&amp;lan=en-US&amp;anchor=Cessna+Skyhawk&amp;index=3&amp;md5=043699ac9126871d47468acf007ad4bb">Cessna Skyhawk</a> aircraft, expected to be delivered in 2027. Infinity Flight Group has steadily expanded its fleet during the last three years, ordering a combined total of 35 new Cessna Skyhawks.
A certified Cessna Pilot Center, Infinity Flight Group currently operates 65 Cessna Skyhawks out of their bases at Trenton-Mercer Airport in New Jersey and Treasure Coast Airport in Ft. Pierce, Florida. The additional aircraft will join the flight school's current fleet of Cessna Skyhawks, enhancing its capacity to train the next generation of aviators.

Textron Aviation Agrees With Infinity Flight Group For Purchase Of 10 Additional Cessna Skyhawk Aircraft, Expected To Be Delivered In 2027

UBS analyst Alex Kramm upgrades Nasdaq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) from Neutral to Buy and raises the price target from $95 to $115.

Upgrades

NDAQ

UBS Upgrades Nasdaq to Buy, Raises Price Target to $115

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">223.7000</td>
<td align="right">0.900</td>
<td align="right">0.40</td>
<td>4.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">136.1182</td>
<td align="right">0.358</td>
<td align="right">0.26</td>
<td>7.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">84.4900</td>
<td align="right">0.190</td>
<td align="right">0.22</td>
<td>1.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">87.6100</td>
<td align="right">0.180</td>
<td align="right">0.20</td>
<td>25.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">53.1400</td>
<td align="right">0.070</td>
<td align="right">0.13</td>
<td>112.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.4700</td>
<td align="right">0.110</td>
<td align="right">0.13</td>
<td>959</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">261.4800</td>
<td align="right">0.090</td>
<td align="right">0.03</td>
<td>28.7K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">108.21</td>
<td align="right">-0.42</td>
<td align="right">-0.39</td>
<td>652</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">42.70</td>
<td align="right">-0.09</td>
<td align="right">-0.22</td>
<td>1.0K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For July 25, 2025

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) with a Market Perform and raises the price target from $168 to $180.

Keefe, Bruyette & Woods Maintains Market Perform on Blackstone, Raises Price Target to $180

Estee Lauder shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight and raised its price target from $62 to $101.

HCA Healthcare shares are trading lower following Q2 reported financial results.

<a href="https://www.theinformation.com/articles/inside-teslas-secretive-optimus-robot-program" title="https://www.theinformation.com/articles/inside-teslas-secretive-optimus-robot-program">https://www.theinformation.com/articles/inside-teslas-secretive-optimus-robot-program</a>

General

TSLA

The Information: Number Of Tesla Optimus Robots Produced Is In The Hundreds So Far, Behind Goal Of 5,000 By End Of Year

Keefe, Bruyette &amp; Woods analyst Christopher Mcgratty reiterates Banc of California (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BANC#NYSE">BANC</a>) with a Outperform and raises the price target from $17 to $18.

BANC

Keefe, Bruyette & Woods Reiterates Outperform on Banc of California, Raises Price Target to $18

VYJUVEK approved for the treatment of DEB from birth with flexible administration options including home dosing and the option for administration by the patient or their family
VYJUVEK is the first and only genetic medicine approved in Japan for the treatment of DEB
PITTSBURGH, July 25, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.krystalbio.com/">Krystal Biotech, Inc.</a> (the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRYS#NASDAQ">KRYS</a>) announced today that on July 24, 2025, Japan's Ministry of Health, Labour and Welfare (MHLW) granted marketing authorization to VYJUVEK&#xAE; (beremagene geperpavec-svdt) for the treatment of wounds in patients with dystrophic epidermolysis bullosa (DEB), starting from birth. VYJUVEK is the first genetic medicine approved in Japan for the treatment of DEB and is designed to address the root cause of the disease by delivering functional copies of the human COL7A1 gene to provide wound healing and sustained functional type VII collagen protein expression with redosing. The Japanese approval allows for dosing at home or in a healthcare setting, with the option for administration by patients or their family members.
As per the approval issued by the MHLW, VYJUVEK is intended for use only in patients with a definite diagnosis of dystrophic epidermolysis bullosa. Genetic testing is not a requirement for treatment.
VYJUVEK is the first genetic medicine approved in Japan for home administration after undergoing regulatory evaluation and environmental safety confirmation for type 1 use in accordance with the Cartagena Act. Approval for home administration was granted based on VYJUVEK's favorable safety profile and minimal risk of environmental dissemination when administered appropriately.
The timing for availability of VYJUVEK in Japan will depend on completion of reimbursement procedures currently underway. The Company currently expects to launch in Japan by the end of this year.
The approval by Japan's MHLW was based on a comprehensive clinical dataset, which included results from an open label extension study conducted in Japanese patients. Results from the Japanese open label extension study closely mirrored prior clinical experience, including the Company's Phase 3 study in the United States, with all four patients that completed the study achieving the primary study endpoint of full wound closure at six months. VYJUVEK was also well tolerated and exhibited a safety profile in Japanese patients that was consistent with previous studies.
The re-examination period for VYJUVEK in Japan is ten years.
VYJUVEK was previously approved by the Food and Drug Administration in the United States in May 2023 and by the European Commission in April 2025.

KRYS

Japan's MHLW Grants Marketing Authorization To Krystal Biotech's VYJUVEK For Treatment Of Wounds In Patients With Dystrophic Epidermolysis Bullosa, Starting From Birth

NatWest Group shares are trading higher after the company reported a year-over-year increase in Q2 financial results.

Scotiabank analyst Nicholas Yulico upgrades SL Green Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLG#NYSE">SLG</a>) from Sector Perform to Sector Outperform and maintains the price target from $71 to $71.

Scotiabank Upgrades SL Green Realty to Sector Outperform, Maintains Price Target to $71

Keefe, Bruyette &amp; Woods analyst Christopher Mcgratty maintains Associated Banc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASB#NYSE">ASB</a>) with a Market Perform and raises the price target from $27 to $28.

Keefe, Bruyette & Woods Maintains Market Perform on Associated Banc, Raises Price Target to $28

Offerings

Aeye, Inc Announces It Filed Amendment To Update Maximum Number of Shares Of The Company's Common Stock To Up To An Aggregate Of $23.728M Placement Shares

Comments

Nature's Miracle Holding

Noticias

Últimas noticias sobre Nature's Miracle Holding (OTC:NMHI) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL